Our #safety committee, the #PRAC, has started 2 reviews:
➡️ one for #topiramate use in pregnancy and the risk of neurodevelopmental disorders in children
➡️ one for #pholcodine-containing medicines due to concerns about the risk of developing severe allergy to other medicines

🐦🔗: https://nitter.eu/EMA_News/status/1565689936702996481